Neurocrine Biosciences (NBIX) had the highest return between June 20, 2014 and July 20, 2015 by a large-cap US stock, returning 244.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Neurocrine Biosciences (NBIX) | 6/20/2014 - 7/20/2015 | 244.9% |
Paycom Soft (PAYC) | 6/20/2014 - 7/20/2015 | 148.81% |
Biomarin Pharmaceutical (BMRN) | 6/20/2014 - 7/20/2015 | 137.7% |
Palo Alto Networks (PANW) | 6/20/2014 - 7/20/2015 | 137.3% |
Axon Enterprise (AXON) | 6/20/2014 - 7/20/2015 | 136.9% |
Genmab A-S (GMAB) | 6/20/2014 - 7/20/2015 | 134.53% |
CyberArk Software (CYBR) | 6/20/2014 - 7/20/2015 | 119.92% |
Coca-Cola Consolidated (COKE) | 6/20/2014 - 7/20/2015 | 110.81% |
DexCom (DXCM) | 6/20/2014 - 7/20/2015 | 108.7% |
Incyte (INCY) | 6/20/2014 - 7/20/2015 | 106.14% |
Vertex Pharmaceuticals (VRTX) | 6/20/2014 - 7/20/2015 | 105.46% |
United Therapeutics (UTHR) | 6/20/2014 - 7/20/2015 | 103.03% |
Electronic Arts (EA) | 6/20/2014 - 7/20/2015 | 100.83% |
NetEase (NTES) | 6/20/2014 - 7/20/2015 | 96.95% |
Interactive Brokers (IBKR) | 6/20/2014 - 7/20/2015 | 96.29% |
Monster Beverage (MNST) | 6/20/2014 - 7/20/2015 | 95.82% |
Centene (CNC) | 6/20/2014 - 7/20/2015 | 94.85% |
Broadcom (AVGO) | 6/20/2014 - 7/20/2015 | 91.69% |
Alnylam Pharmaceuticals (ALNY) | 6/20/2014 - 7/20/2015 | 89.08% |
Regeneron Pharmaceuticals (REGN) | 6/20/2014 - 7/20/2015 | 88.95% |
Edwards Lifesciences (EW) | 6/20/2014 - 7/20/2015 | 82.76% |
Burlington Stores (BURL) | 6/20/2014 - 7/20/2015 | 77.72% |
Ulta Beauty (ULTA) | 6/20/2014 - 7/20/2015 | 77.19% |
XPO Logistics (XPO) | 6/20/2014 - 7/20/2015 | 75.94% |
Netflix (NFLX) | 6/20/2014 - 7/20/2015 | 75.4% |
Large-cap stocks are treated as having a market cap of $10B+.
